Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

360 Photos | 360 View Photos

This 360 degree view shows staff at the University of Colorado Heart and Vascular Center performing live transesophageal ...

Home October 02, 2019
Home
Videos | Cardiovascular Business

A discussion with Ruth Fisher, MBA, vice president of the Henry Ford Hospital structural heart program, and Janet Wyman ...

Home September 30, 2019
Home
Videos | Heart Valve Technology

Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of the ...

Home September 30, 2019
Home
Videos | Structural Heart

A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice ...

Home September 30, 2019
Home
Technology | Heart Valve Technology

September 24, 2019 – Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Evolut ...

Home September 24, 2019
Home
News | Congenital Heart

September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm ...

Home September 20, 2019
Home
News | Leads Implantable Devices

September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...

Home September 20, 2019
Home
News | Heart Valve Technology

September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...

Home September 05, 2019
Home
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.
Feature | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home September 03, 2019
Home
An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire
Feature | Heart Valve Technology

A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve ...

Home August 27, 2019
Home
News | Heart Valve Technology

August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst ...

Home August 22, 2019
Home
FDA Approves Sapien 3, CoreValve Evolut TAVR Valves for Low-risk Patients
Feature | Heart Valve Technology | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor

August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of transcatheter ...

Home August 16, 2019
Home
Subscribe Now